详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

Mechanisms of action of the BCL-2 inhibitor venetoclax in multiple myeloma: a literature review

文献详情

资源类型：

Pubmed体系：

作者：

机构： [1]Department of Earth Sciences, Kunming University of Science and Technology, Kunming, China. [2]Department of Pharmacy, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. [3]College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, China. [4]Undergraduate Department, Taishan University, Taian, China. [5]School of Public Health, Nanchang University, Nanchang, China. [6]Institute of Medical Information/Library, Chinese Academy of Medical Sciences, Beijing, China. [7]Division of Sports Science & Physical Education, Tsinghua University, Beijing, China.

出处：

DOI：

ISSN：

关键词： cell apoptosis multiple myeloma anti-cancer drug cell cycle targeted therapies

摘要：

Abnormal cellular apoptosis plays a pivotal role in the pathogenesis of Multiple Myeloma (MM). Over the years, BCL-2, a crucial anti-apoptotic protein, has garnered significant attention in MM therapeutic research. Venetoclax (VTC), a small-molecule targeted agent, effectively inhibits BCL-2, promoting the programmed death of cancerous cells. While VTC has been employed to treat various hematological malignancies, its particular efficacy in MM has showcased its potential for broader clinical applications. In this review, we delve into the intricacies of how VTC modulates apoptosis in MM cells by targeting BCL-2 and the overarching influence of the BCL-2 protein family in MM apoptosis regulation. Our findings highlight the nuanced interplay between VTC, BCL-2, and MM, offering insights that may pave the way for optimizing therapeutic strategies. Through this comprehensive analysis, we aim to lay a solid groundwork for future explorations into VTC's clinical applications and the profound effects of BCL-2 on cellular apoptosis.Copyright © 2023 Cao, Wu, Zhang, Gong, Chen, You, Shen, Qiang and Cao.

基金：

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2023]版：

大类 | 2 区医学

小类 | 2 区药学

最新[2023]版：

大类 | 2 区医学

小类 | 2 区药学

第一作者：

第一作者机构： [1]Department of Earth Sciences, Kunming University of Science and Technology, Kunming, China. [2]Department of Pharmacy, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.

共同第一作者：

通讯作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]PP2A mediates apoptosis or autophagic cell death in multiple myeloma cell lines [2]PP2A mediates apoptosis or autophagic cell death in multiple myeloma cell lines [3]RSPH14 regulates the proliferation, cell cycle progression, and apoptosis of non-small cell lung cancer cells [4]Sphingosine 1-phosphate regulates proliferation, cell cycle and apoptosis of hepatocellular carcinoma cells via syndecan-1. [5]SOX11 regulates apoptosis and cell cycle in hepatocellular carcinoma via Wnt/β-catenin signaling pathway. [6]Molecular mechanisms underlying mangiferin-induced apoptosis and cell cycle arrest in A549 human lung carcinoma cells [7]CENPL accelerates cell proliferation, cell cycle, apoptosis, and glycolysis via the MEK1/2-ERK1/2 pathway in hepatocellular carcinoma [8]三氧化二砷联合长春瑞滨、多西他赛对神经母细胞瘤SK-N-SH细胞系杀伤作用和细胞周期的影响 [9]Knockdown of GBAS regulates esophageal cancer cell viability and apoptosis. [10]姜黄素对人肝癌细胞株HepG2凋亡和细胞周期的影响